Drug-drug interactions with CFTR modulator therapy in cystic fibrosis: Focus on Trikafta®/Kaftrio®-Reference-Cited by-同舟云学术

Drug-drug interactions with CFTR modulator therapy in cystic fibrosis: Focus on Trikafta®/Kaftrio®

Published:2023-05 Issue:3 Volume:22 Page:478-483
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Purkayastha Debanjali,Agtarap Kyla,Wong Kristy^ORCID,Pereira Onella,Co Jannie,Pakhale Smita,Kanji Salmaan^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference31 articles.

1. Cystic fibrosis;O'Sullivan;Lancet,2009

2. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele;Middleton;N Engl J Med,2019

3. State of the art on approved cystic fibrosis transmembrane conductance regulator (CFTR) modulators and triple-combination therapy;Meoli;Pharmaceuticals,2021

4. TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)[product monograph]. Toronto, Ontario, Canada: 2023;Vertex Pharmaceuticals (Canada) Inc.

5. European Medicines Agency. Kaftrio [Available from: 2023; https://www.ema.europa.eu/en/documents/product-information/kaftrio-epar-product-information_en.pdf.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging biomarkers for precision diagnosis and personalized treatment of cystic fibrosis;Journal of Rare Diseases;2024-09-13

2. Effets indésirables de l’association tezacaftor/ivacaftor/elexacaftor pouvant mener à un arrêt de traitement : à propos d’une série de 10 cas;Therapies;2024-07

3. Triazole antifungal drug interactions—practical considerations for excellent prescribing;Journal of Antimicrobial Chemotherapy;2024-04-17

4. Long-Term Follow-Up of Health-Related Quality of Life and Short-Term Intervention with CFTR Modulator Therapy in Adults with Cystic Fibrosis: Evaluation of Changes over Several Years with or without 33 Weeks of CFTR Modulator Therapy;Healthcare;2023-10-31

5. YES1 Kinase Mediates the Membrane Removal of Rescued F508del-CFTR in Airway Cells by Promoting MAPK Pathway Activation via SHC1;Biomolecules;2023-06-06